298 results on '"Case, Brian C."'
Search Results
2. From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunction
3. Coronary Microvascular Disease Registry (CMDR): Study design and rationale
4. Racial Disparities in Outcomes of Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Secondary to Spontaneous Coronary Artery Dissection
5. Review of late-breaking clinical trials from Cardiovascular Research Technologies (CRT) 2024
6. Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry
7. The impact of cusp overlap on permanent pacemaker requirement following self-expanding transcatheter aortic valve replacement
8. High-risk percutaneous coronary intervention with or without mechanical circulatory support: Will Impella show superiority in the PROTECT IV randomized trial?
9. Coronary microvascular dysfunction and inflammation: Insights from the Coronary Microvascular Disease Registry
10. Exploring the interplay between coronary microvascular dysfunction and mental health
11. Comparing planned versus ad hoc coronary microvascular assessment: Early findings from the Coronary Microvascular Disease Registry
12. Aspirin Versus Warfarin after Transcatheter Aortic Valve Replacement in Low-Risk Patients: 2-Year Follow-Up
13. Understanding Patient Characteristics and Coronary Microvasculature: Early Insights from the Coronary Microvascular Disease Registry
14. Clinical Profile and Outcomes of Patients With Pure Aortic Regurgitation Who Underwent Surgical Aortic Valve Replacement
15. Impact of left bundle branch block or permanent pacemaker after transcatheter aortic valve replacement on mid-term left ventricular ejection fraction
16. Review of late-breaking trials from CRT 2023
17. Investigating Electrocardiographic Abnormalities in Patients with Coronary Microvascular Dysfunction
18. Temporal trends with the Evolut family of self‐expanding transcatheter heart valves: A single‐center experience
19. Covered aortic stent for primary transcaval closure: Case report
20. Is there additional value in adding Impella to veno-arterial extracorporeal membrane oxygenation in patients with cardiogenic shock?
21. False Reassurance
22. Coronary microvascular dysfunction and cancer therapy-related cardiovascular toxicity
23. A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique
24. Frequency of ventriculography during left heart catheterization for radial vs. femoral access
25. North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality
26. Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart – portable extracorporeal heart perfusion and monitoring system
27. Myocardial infarction as the initial presentation of essential thrombocytosis in a young patient
28. High-Risk Percutaneous Coronary Intervention of Native Coronary Arteries Without Mechanical Circulatory Support in Acute Coronary Syndrome Without Cardiogenic Shock
29. From Chest Pain to Coronary Functional Testing: Clinical and Economic Impact of Coronary Microvascular Dysfunction
30. Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic
31. Early Leaflet Thickening, Durability and Bioprosthetic Valve Failure in TAVR
32. Abstract 13997: What is the Role of Pulmonary Artery Catheterization in Patients With Acute Myocardial Infarction Complicated With Cardiogenic Shock?
33. Abstract 10255: The Evolving Impact of Myocardial Injury in COVID-19 Patient Amid the Omicron Wave of the Pandemic
34. Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects.
35. Unveiling the value of left ventriculography in ST-elevation myocardial infarction
36. Understanding the Reasons for Disparities in Screening of Minorities in Cardiovascular Clinical Trials: Insights from a Large Clinical Research Center
37. Disparities in Screening and Enrollment of Minorities Into Cardiovascular Clinical Trials
38. Evolution of Myocarditis Incidence at a Large Healthcare System Before and During COVID-19 Pandemic
39. Longitudinal Evolution and Experience With the Evolut Family of Self-Expandable Transcatheter Heart Valves
40. Disparities in Screening Minorities Into Cardiovascular Clinical Trials: Insights From a Large Clinical Research Center
41. The Impact of the Cusp Overlap Technique on Permanent Pacemaker Requirement Following Transcatheter Aortic Valve Replacement With a Self-Expanding Valve
42. CT Simulation of Redo TAVR With Deep Implantation of Balloon-Expandable Within Self-Expanding Valve
43. Post-Myocardial Infarction Free-Wall Rupture
44. LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry
45. Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
46. The Evolving Impact of Myocardial Injury in Patients With COVID-19 Amid the Omicron Wave of the Pandemic
47. Association of Statins With Nonculprit Coronary Lesions and Adverse Events (from the LRP Study)
48. CRT-700.02 CT Simulation of Redo TAVR With Deep Implantation of Balloon-Expandable Within Self-Expanding Valve
49. Ice Ice Maybe… Not
50. CRT-600.12 Disparities in Screening Minorities Into Cardiovascular Clinical Trials: Insights From a Large Clinical Research Center
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.